Current concepts in the etiology and treatment of Behçet disease

Survey of Ophthalmology

Volumn 50, Issue 4, 2005, Pages 297-350

  Evereklioglu, Cem ^a,b  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^b NONE   (Turkey)

Author keywords

Beh et disease; Etanercept; Etiopathogenesis; Infliximab; Interferon ; Tacrolimus (FK 506); Thalidomide; Treatment; Tumor necrosis factor

Indexed keywords

ACETYLSALICYLIC ACID; ALEMTUZUMAB; ALPHA INTERFERON; ANTICOAGULANT AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; BENZATHINE PENICILLIN; CALCINEURIN INHIBITOR; CHLORAMBUCIL; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOPLEGIC AGENT; CYCLOSPORIN; DAPSONE; ETANERCEPT; FLUOROMETHOLONE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MYDRIATIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RETINA S ANTIGEN; RIFABUTIN; TACROLIMUS; THALIDOMIDE; UNINDEXED DRUG;

ABDOMINAL AORTA ANEURYSM; ALOPECIA; ANASTOMOSIS LEAKAGE; ANEMIA; ANEURYSM RUPTURE; ANKYLOSING SPONDYLITIS; ARTERY THROMBOSIS; ARTHROPATHY; BEHCET DISEASE; BIRTH DEFECT; BLINDNESS; BLOOD DYSCRASIA; BONE MARROW SUPPRESSION; BRAIN VASCULITIS; BREAST TENDERNESS; CATARACT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; CONSTIPATION; CRYOGLOBULINEMIA; CUSHINGOID SYNDROME; CYTOMEGALOVIRUS INFECTION; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE EXACERBATION; DIZZINESS; EDEMA; ELECTROLYTE DISTURBANCE; ENDOPHTHALMITIS; EOSINOPHILIA; EPIDIDYMITIS; ERYTHEMA NODOSUM; ESOPHAGUS PERFORATION; EYE SYNECHIA; FLUID RETENTION; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; GENITAL ULCER; GINGIVA HYPERPLASIA; GINGIVA HYPERTROPHY; GROWTH RETARDATION; HEADACHE; HEMOLYSIS; HEMOPTYSIS; HEMORRHAGIC CYSTITIS; HEPATORENAL SYNDROME; HIRSUTISM; HUMAN; HYPERGLYCEMIA; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRICHOSIS; HYPERURICEMIA; HYPOPYON; INFERTILITY; INTERMEDIATE UVEITIS; INTERSTITIAL PNEUMONIA; INTESTINE PERFORATION; INTESTINE ULCER; INTRAOCULAR HYPERTENSION; INTRAOCULAR HYPOTENSION; INTRAOCULAR TUMOR; IRIDOCYCLITIS; IRIS ATROPHY; JAUNDICE; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LEUKOCYTOSIS; LEUKOPENIA; LIVER TOXICITY; LUNG FIBROSIS; LYMPHADENOPATHY; MENTAL DISEASE; METHEMOGLOBINEMIA; MONARTHRITIS; MOUTH ULCER; MUSCLE SPASM; MYALGIA; NAUSEA; NEOVASCULAR GLAUCOMA; NEPHROTOXICITY; NEUROPATHY; NEUROTOXICITY; NONHUMAN; NONKETOTIC DIABETIC COMA; OPEN ANGLE GLAUCOMA; OPHTHALMOPLEGIA; OPTIC NERVE ATROPHY; OPTIC NERVE LESION; OSTEOPOROSIS; PAPILLEDEMA; PAPILLITIS; PEPTIC ULCER; PERCEPTION DEAFNESS; PHOTOPHOBIA; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PULMONARY ARTERY ANEURYSM; PYODERMA GANGRENOSUM; RASH; RECURRENT DISEASE; RELAPSE; RETINA ARTERITIS; RETINA BLOOD VESSEL OCCLUSION; RETINA DETACHMENT; RETINA HEMORRHAGE; RETINA INJURY; RETINA ISCHEMIA; RETINA MACULA CYSTOID EDEMA; RETINA MACULA DEGENERATION; RETINA MACULA HOLE; RETINA MACULOPATHY; RETINA NEOVASCULARIZATION; RETINA TEAR; RETINA VASCULITIS; RETINA VEIN OCCLUSION; RETINOBLASTOMA; REVIEW; SCLERITIS; SEDATION; SIDE EFFECT; SKIN ATROPHY; SOMNOLENCE; SPONDYLOARTHROPATHY; SPONTANEOUS ABORTION; TERATOGENICITY; THORAX DISEASE; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOPHLEBITIS; TONIC CLONIC SEIZURE; VEIN THROMBOSIS; VISUAL IMPAIRMENT; VITREORETINOPATHY; VITREOUS BODY DETACHMENT; VITREOUS HEMORRHAGE; WEIGHT GAIN; WOUND HEALING IMPAIRMENT; XEROSTOMIA;

BEHCET SYNDROME; DIAGNOSIS, DIFFERENTIAL; HUMANS;

EID: 20444483616     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2005.04.009     Document Type: Review

References (515)

1. O. Abadoǧlu, E. Osma, and E.S. Uçan Behçet's disease with pulmonary involvement, superior vena cava syndrome, chyloptysis and chylous ascites Respir Med 90 1996 429 431
2. A. Accardo-Palumbo, G. Triolo, and M.C. Carbone Polymorphonuclear leukocyte myeloperoxidase levels in patients with Behçet's disease Clin Exp Rheumatol 18 2000 495 498
3. T. Acican, and O.U. Gürkan Azathiopine-steroid combination therapy for pulmonary arterial aneurysms in Behçet's disease Rheumatol Int 20 2001 171 174
4. B. Adam, and E. Çalikoglu Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behçet's disease J Eur Acad Dermatol Venereol 18 2004 318 320
5. T. Ahmad, M. Neville, and S.E. Marshall Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC Hum Mol Genet 12 2003 647 656
6. T. Ahmad, G.R. Wallace, and T. James Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum 48 2003 807 813
7. E. Ak, U. Harputluoglu, F. Oghan, and B. Baykal Behçet's disease and hearing loss Auris Nasus Larynx 31 2004 29 33
8. N. Akdeniz, M. Eşrefoglu, and M.S. Keleş Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behçet's disease Ann Acad Med Singapore 33 2004 596 599
9. G. Akman-Demir, S. Bahar, and O. Çoban Cranial MRI in Behçet's disease: 134 examinations of 98 patients Neuroradiology 45 2003 851 859
10. G. Akman-Demir, P. Serdaroglu, and B. Taşçi Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group Brain 122 1999 2171 2182
11. T. Akpolat, M. Akkoyunlu, and I. Akpolat Renal Behçet's disease: a cumulative analysis Semin Arthritis Rheum 31 2002 317 337
12. T. Akpolat, B. Diri, and Y. Oguz Behçet's disease and renal failure Nephrol Dial Transplant 18 2003 888 891
13. K. Aksu, Y. Kabasakal, and A. Sayiner Prevalences of hepatitis A, B, C and E viruses in Behçet's disease Rheumatology (Oxford) 38 1999 1279 1281
14. K. Aksu, N. Turgan, and F. Oksel Hyperhomocysteinaemia in Behçet's disease Rheumatology (Oxford) 40 2001 687 690
15. A. Al-Araji, K. Sharquie, and Z. Al-Rawi Prevalence and patterns of neurological involvement in Behçet's disease: a prospective study from Iraq J Neurol Neurosurg Psychiatry 74 2003 608 613
16. S.A. Al-Fahad, and A.H. Al-Araji Neuro-Behçet's disease in Iraq: a study of 40 patients J Neurol Sci 170 1999 105 111
17. B. Alevizos, C. Anagnostara, and G.N. Christodoulou Resistant bipolar disorder precipitated by Behçet's syndrome Bipolar Disord 6 2004 260 263
18. G. Alper, Y. Yilmaz, G. Ekinci, and O. Köse Cerebral vein thrombosis in Behçet's disease Pediatr Neurol 25 2001 332 335
19. E. Alpsoy, L. Donmez, and A. Bacanli Review of the chronology of clinical manifestations in 60 patients with Behçet's disease Dermatology 207 2003 354 356
20. E. Alpsoy, C. Durusoy, and E. Yilmaz Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study Arch Dermatol 138 2002 467 471
21. E. Alpsoy, G.O. Elpek, and F. Yilmaz Androgen receptor levels of oral and genital ulcers and skin pathergy test in patients with Behçet's disease Dermatology 210 2005 31 35
22. E. Alpsoy, H. Er, C. Durusoy, and E. Yilmaz The use of sucralfate suspension in the treatment of oral and genital ulceration of Behçet disease: a randomized, placebo-controlled, double-blind study Arch Dermatol 135 1999 529 532
23. E. Alpsoy, S. Uzun, and A. Akman Histological and immunofluorescence findings of non-follicular papulopustular lesions in patients with Behçet's disease J Eur Acad Dermatol Venereol 17 2003 521 524
24. M.R. Altiparmak, M. Tanverdi, and O.N. Pamuk Glomerulonephritis in Behçet's disease: report of seven cases and review of the literature Clin Rheumatol 21 2002 14 18
25. Z. Amoura, C. Dodé, and S. Hue Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Behçet's disease Arthritis Rheum 52 2005 608 611
26. K. Ando, Y. Fujino, and K. Hijikata Epidemiological features and visual prognosis of Behçet's disease Jpn J Ophthalmol 43 1999 312 317
27. M. Andreu, J. Ramanoelina, and F. Fajnkuchen [Treatment of severe Behçet's disease with anti-TNF-α: infliximab. A case report] Ann Med Interne (Paris) 153 2002 414 415
28. T. Arayssi, R. Hamra, and S. Awwad Treatment of refractory vitritis in Behçet disease with infliximab Arthritis Rheum 46 2002 181
29. B.C. Aridogan, M. Yildirim, and V. Baysal Serum Levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behçet's disease J Dermatol 30 2003 602 607
30. F. Atalay, D. Ernam, F. Okten, and N. Akar Elevated FVIII and FIX level in a Behçet's disease patient with intracardiac thrombosis and pulmonary arterial aneurysms Thromb Res 115 2005 159 161
31. G. Atalay, E. Eksioglu-Demiralp, T. Akoglu, and H. Direskeneli The effects of nitric oxide donors and inhibitors on neutrophil functions in Behçet's disease Clin Exp Rheumatol 20 2002 S17 20
32. A. Ateş, O. Aydintuǧ, and U. Olmez Serum homocysteine level is higher in Behcet's disease with vascular involvement Rheumatol Int 25 2005 42 44
33. L.S. Atmaca, and F. Batioǧlu The efficacy of cyclosporin A in the treatment of Behçet's disease Ophthalmic Surg 25 1994 321 327
34. L.S. Atmaca, F. Batioǧlu, and A. Idil Retinal and disc neovascularization in Behçet's disease and efficacy of laser photocoagulation Graefes Arch Clin Exp Ophthalmol 234 1996 94 99
35. L.S. Atmaca, and P.A. Sonmez Fluorescein and indocyanine green angiography findings in Behçet's disease Br J Ophthalmol 87 2003 1466 1468
36. O. Avci, E. Ellidokuz, and I. Simşek Helicobacter pylori and Behçet's disease Dermatology 199 1999 140 143
37. M.C. Avunduk, A.M. Avunduk, and E. Oztekin Etanercept treatment in the endotoxin-induced uveitis of rats Exp Eye Res 79 2004 357 365
38. M. Aygündüz, N. Bavbek, and M. Öztürk Serum beta 2-microglobulin reflects disease activity in Behçet's disease Rheumatol Int 22 2002 5 8
39. E. Aykutlu, B. Baykan, and P. Serdaroglu Epileptic seizures in Behçet disease Epilepsia 43 2002 832 835
40. G. Azizlerli, A.A. Köse, and R. Sarica Prevalence of Behçet's disease in Istanbul, Turkey Int J Dermatol 42 2003 803 806
41. G. Azizlerli, R. Sarica, and A. Köse Interferon alfa-2a in the treatment of Behçet's disease Dermatology 192 1996 239 241
42. D. Bang, Y.S. Chun, and I.B. Haam The influence of pregnancy on Behçet's disease Yonsei Med J 38 1997 437 443
43. Y. Bardak, and B.C. Aridogan The demonstration of serum interleukin 6-8, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Behçet's disease with ocular involvement Ocul Immunol Inflamm 12 2004 53 58
44. C.G. Barnes, and H. Yazici Behçet's syndrome Rheumatology (Oxford) 38 1999 1171 1174
45. F. Batioǧlu, L.S. Atmaca, H.G. Karabulut, and D. Beyza Sayin Factor V Leiden and prothrombin gene G20210A mutations in ocular Behçet disease Acta Ophthalmol Scand 81 2003 283 285
46. V. Bautista-Hernandez, F. Gutierrez, and A. Capel Endovascular repair of concomitant celiac trunk and abdominal aortic aneurysms in a patient with Behçet's disease J Endovasc Ther 11 2004 222 225
47. Y.A. Bayazit, C. Evereklioǧlu, and E. Ozer Neurotological status in Behçet's disease and its ophthalmological correlates Postgrad Med J 80 2004 724 728
48. Y. Bayraktar, E. Özaslan, and D.H. Van Thiel Gastrointestinal manifestations of Behçet's disease J Clin Gastroenterol 30 2000 144 154
49. T. Baysal, H.I. Özişik, and R. Karlidag Proton MRS in Behçet's disease with and without neurological findings Neuroradiology 45 2003 860 864
50. H. Behçet Uber rezidivierende Aphthose, durch ein Virus verursachte Geschwure am Mund, am Auge und an den Genitalien Dermatol Wochenschr 105 1937 1152 1157
51. M. Ben Ahmed, H. Houman, and M. Miled Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease Arthritis Rheum 50 2004 2291 2295
52. D. BenEzra, and E. Cohen Treatment and visual prognosis in Behçet's disease Br J Ophthalmol 70 1986 589 592
53. D. BenEzra, E. Cohen, and T. Chajek Evaluation of conventional therapy versus cyclosporine A in Behçet's syndrome Transplant Proc 20 1988 136 143
54. D. BenEzra, G. Maftzir, and V. Barak Blood serum interleukin-1 receptor antagonist in pars planitis and ocular Behçet disease Am J Ophthalmol 123 1997 593 598
55. J.M. Benitez-De-Castillo, J.M. Martinez-De-La-Casa, and E. Pato-Cour Long-term treatment of refractory posterior uveitis with anti-TNFα (infliximab) Eye 2004 (E Pub) in press doi:10.1038/sj.eye.6701689
56. A. Birol, S. Ulkatan, M. Kocak, and E. Erkek Peripheral neuropathy in Behçet's disease J Dermatol 31 2004 455 459
57. L. Boiardi, C. Salvarani, and B. Casali Intercellular adhesion molecule-1 gene polymorphisms in Behçet's disease J Rheumatol 28 2001 1283 1287
58. Borlu M, Ukşal Ü, Ferahbaş A, Evereklioglu C: Clinical features of Behçet's disease in children. Int J Dermatol (in press)
59. A. Bouloumié, V.B. Schini-Kerth, and R. Busse Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells Cardiovasc Res 41 1999 773 780
60. B.N. Bouma, and L.O. Mosnier Thrombin activatable fibrinolysis inhibitor (TAFI) at the interface between coagulation and fibrinolysis Pathophysiol Haemost Thromb 33 2004 375 381
61. S.R. Boyd, S. Young, and S. Lightman Immunopathology of the noninfectious posterior and intermediate uveitides Surv Ophthalmol 46 2001 209 233
62. R. Brik, H. Shamali, and R. Bergman Successful thalidomide treatment of severe infantile Behçet's disease Pediatr Dermatol 18 2001 143 145
63. C.H. Buckley, P.W. Hadoke, and C.J. O'Brien Role of the endothelium in modulating functional responses of isolated bovine anterior ciliary arteries to vasoconstrictor agonists Br J Ophthalmol 82 1998 826 829
64. G. Bükülmez, T. Akan, and G. Ciliv Serum adenosine deaminase levels in patients with psoriasis: a prospective case-control study EurJ Dermatol 10 2000 274 276
65. I. Caca, H. Nazaroglu, and K. Ünlü Color doppler imaging of ocular hemodynamic changes in Behçet's disease Jpn J Ophthalmol 48 2004 101 105
66. M. Cahill, M. Karabatzaki, and R. Meleady Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease Br J Ophthalmol 84 2000 154 157
67. L. Calabrese, and A.B. Fleischer Thalidomide: current and potential clinical applications Am J Med 108 2000 487 495
68. N. Cengiz, M. Şahin, and M. Onar Correlation of clinical, MRI and Tc-99m HMPAO SPECT findings in neuro-Behçet's disease Acta Neurol Belg 104 2004 100 105
69. P.S. Chavis, and K.F. Tabbara Behçet's disease Int Ophthalmol Clin 35 1995 43 67
70. M. Coşkun, A. Bacanli, and N. Sallakci Specific interleukin-1 gene polymorphisms in Turkish patients with Behçet's disease Exp Dermatol 14 2005 124 129
71. N. Çakir, E. Derviş, and O. Benian Prevalence of Behçet's disease in rural western Turkey: a preliminary report Clin Exp Rheumatol 22 2004 53 55
72. M. Çalgüneri, I. Ertenli, and S. Kiraz Effect of prophylactic benzathine penicilline on mucocutaneous symptoms of Behçet's disease Dermatology 192 1996 125 128
73. M. Çalgüneri, S. Kiraz, and I. Ertenli The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behçet's disease: a randomized clinical trial Arthritis Rheum 39 1996 2062 2065
74. M. Çalgüneri, A.M. Onat, and M.A. Öztürk Transverse myelitis in a patient with Behçet's disease: favorable outcome with a combination of interferon-α Clin Rheumatol 24 2005 64 66
75. M. Çalgüneri, M.A. Öztürk, and I. Ertenli Effects of interferon-α treatment on the clinical course of refractory Behçet's disease: an open study Ann Rheum Dis 62 2003 492 493
76. A. Canataroglu, K. Tanriverdi, and T. Inal Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Behçet's disease Rheumatol Int 23 2003 236 240
77. A. Carletto, M. Pacor, and D. Biasi Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Behçet's disease J Rheumatol 24 1997 1332 1336
78. M. Cekmen, C. Evereklioglu, and H. Er Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome Int J Dermatol 42 2003 870 875
79. B. Çelet, G. Akman-Demir, and P. Serdaroglu Anti-αβ- crystallin immunoreactivity in inflammatory nervous system diseases J Neurol 247 2000 935 939
80. M. Cemri, A. Erkan, M. Ozdemir, and A. Gengel Behçet's disease with a large and free right atrial thrombus Eur J Echocardiogr 3 2002 233 235
81. B. Çetinel, H. Akpinar, and I. Tüfek Bladder involvement in Behçet's syndrome J Urol 161 1999 52 56
82. H. Ceyran, Y. Akçali, and C. Kahraman Surgical treatment of vasculo-Behçet's disease. A review of patients with concomitant multiple aneurysms and venous lesions Vasa 32 2003 149 153
83. J.C. Chambers, D.O. Haskard, and J.S. Kooner Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome J Am Coll Cardiol 37 2001 517 520
84. D.G. Charteris, C. Champ, A.R. Rosenthal, and S.L. Lightman Behçet's disease: activated T lymphocytes in retinal perivasculitis Br J Ophthalmol 76 1992 499 501
85. M. Cho, T.K. Hunt, and M.Z. Hussain Hydrogen peroxide stimulates macrophage vascular endothelial growth factor release Am J Physiol Heart Circ Physiol 280 2001 2357 2363
86. Y.H. Cho, J. Jung, and K.H. Lee Clinical features of patients with Behçet's disease and epididymitis J Urol 170 2003 1231 1233
87. I.J. Choi, J.S. Kim, and S.D. Cha Long-term clinical course and prognostic factors in intestinal Behçet's disease Dis Colon Rectum 43 2000 692 700
88. A. D'Angelo, and J. Selhub Homocysteine and thrombotic disease Blood 90 1997 1 11
89. F. Davatchi, F. Shahram, and H. Chams High dose methotrexate for ocular lesions of Behçet's disease. Preliminary short-term results Adv Exp Med Biol 528 2003 579 584
90. F. Davatchi, F. Shahram, and H. Chams Methotrexate for ocular lesions of Behçet's disease. Cohort study on 262 patients Arthritis Rheum 41 1998 356
91. U.M. Davies, R.G. Palmer, and A.M. Denman Treatment with acyclovir does not affect orogenital ulcers in Behçet's syndrome: a randomized double-blind trial Br J Rheumatol 27 1988 300 302
92. M.D. de Smet, G. Bitar, S. Mainigi, and R.B. Nussenblatt Human S-antigen determinant recognition in uveitis Invest Ophthalmol Vis Sci 42 2001 3233 3238
93. M.D. de Smet, and M. Dayan Prospective determination of T-cell responses to S-antigen in Behçet's disease patients and controls Invest Ophthalmol Vis Sci 41 2000 3480 3484
94. Q.H. Dé Tran, E. Guay, S. Chartier, and J. Tousignant Tacrolimus in dermatology J Cutan Med Surg 5 2001 329 335
95. B. de Wazieres, H. Gil, and N. Magy Treatment of recurrent ulceration with low doses of thalidomide: pilot study in 17 patients Rev Med Interne 20 1999 567 570
96. L. Deng, W. Ding, and R.D. Granstein Thalidomide inhibits tumor necrosis factor-α production and antigen presentation by Langerhans cells J Invest Dermatol 121 2003 1060 1065
97. A.D. Dick Experimental approaches to specific immunotherapies in autoimmune disease. Future treatment of endogenous posterior uveitis? Br J Ophthalmol 97 1995 81 88
98. H. Direskeneli Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51 Ann Rheum Dis 60 2001 996 1002
99. H. Direskeneli, E. Eksioglu-Demiralp, and A. Kibaroglu Oligoclonal T cell expansions in patients with Behçet's disease Clin Exp Immunol 117 1999 166 170
100. H. Direskeneli, E. Ekşioglu-Demiralp, and S. Yavuz T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet's disease J Rheumatol 27 2000 708 713
101. H. Direskeneli, G. Keser, and D. D'Cruz Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's disease Clin Rheumatol 14 1995 55 61
102. H. Direskeneli, and G. Saruhan-Direskeneli The role of heat shock proteins in Behçet's disease Clin Exp Rheumatol 21 2003 44 48
103. A. Dönmez, K. Aksu, and H.A. Çelik Thrombin activatable fibrinolysis inhibitor in Behçet's disease Thromb Res 115 2005 287 292
104. S. Dündar, and I. Özcebe Behçet's disease and interferon: flaws in research integrity of randomized trial Lancet 356 2000 1351
105. Duygulu F, Evereklioglu C, Çaliş M,, et al. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease; a pilot study. Clin Rheumatol (in press)
106. J. Duymaz-Tozkir, V. Yilmaz, and F.A. Uyar Polymorphisms of the IL-8 and CXCR2 genes are not associated with Behçet's disease J Rheumatol 32 2005 93 97
107. N. Düzgün, and A. Ateş Erosive arthritis in a patient with Behçet's disease Rheumatol Int 23 2003 265 267
108. N. Düzgün, E. Ayaşlioglu, and H. Tutkak Serum soluble CD30 levels in Behçet's disease Clin Exp Rheumatol 22 2004 17 20
109. M.A. Edres, C. Scully, and M. Gelbier Use of proprietary agents to relieve recurrent aphthous stomatitis Br Dent J 182 1997 144 146
110. G.E. Ehrlich Vasculitis in Behçet's disease Int Rev Immunol 14 1997 81 88
111. + T cell subsets in Behçet's disease Rheumatol Int 19 1999 23 26
112. E. Ekşioglu-Demiralp, A. Kibaroglu, and H. Direskeneli Phenotypic characteristics of B cells in Behçet's disease: increased activity in B cell subsets J Rheumatol 26 1999 826 832
113. K.M. El Ramahi, A. Al Dalaan, and A. Al Shaikh Renal involvement in Behçet's disease: review of 9 cases J Rheumatol 25 1998 2254 2260
114. U. Elgin, N. Berker, and A. Batman Incidence of secondary glaucoma in Behçet disease J Glaucoma 13 2004 441 444
115. J. Elidan, E. Cohen, H. Levi, and D. BenEzra Effect of cyclosporine A on the hearing loss in Behçet's disease Ann Otol Rhinol Laryngol 100 1991 464 468
116. H. Er, C. Evereklioglu, and T. Cumurcu Serum homocysteine level is increased and correlated with endothelin1 and nitric oxide in Behçet's disease Br J Ophthalmol 86 2002 653 657
117. F. Erdem, M. Gündogdu, and I. Kiki Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease Rheumatol Int, (in press) 15 2004
118. A. Erel, E. Özsoy, and G. Biberoglu Serum levels of vitamins A, C, and E, beta-carotene, selenium, and zinc in patients with Behçet's disease: a controlled study Biol Trace Elem Res 95 2003 97 106
119. T. Ergün, Ü. Ince, and E. Ekşioglu-Demiralp HSP 60 expression in mucocutaneous lesions of Behçet's disease J Am Acad Dermatol 45 2001 904 909
120. F. Erkan, and T. Çavdar Pulmonary vasculitis in Behçet's disease Am Rev Respir Dis 146 1992 232 239
121. F. Erkan, A. Gül, and E. Tasali Pulmonary manifestations of Behçet's disease Thorax 56 2001 572 578
122. F. Erkan, E. Kiyan, and A. Tunaci Pulmonary complications of Behçet's disease Clin Chest Med 23 2002 493 503
123. K. Erkiliç, C. Evereklioglu, and M. Çekmen Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations Mediators Inflamm 12 2003 107 116
124. N.A. Ermakova Comparative evaluation of the effectiveness of corticosteroids and cytostatics in treating retinal angiitis in Behçet's disease Vestn Oftalmol 118 2002 32 35
125. S. Kiraz, M.A. Oztürk, and I. Ertenli Parvovirus B19 infection in Behçet's disease Ann Rheum Dis 60 2001 814 815
126. S. Esin, A. Gül, and V. Hodara Peripheral blood T cell expansions in patients with Behçet's disease Clin Exp Immunol 107 1997 520 527
127. G. Espinosa, J. Font, and D. Tassies Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin Am J Med 112 2002 37 43
128. C. Estrach, S. Mpofu, and R.J. Moots Behçet's syndrome: response to infliximab after failure of etanercept Rheumatology (Oxford) 41 2002 1213 1214
129. C.A. Evans, J. Jellis, and S.P. Hughes Tumor necrosis factor-α, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuberculous osteomyelitis J Infect Dis 177 1998 1582 1587
130. C. Evereklioglu Managing the symptoms of Behçet's disease Expert Opin Pharmacother 5 2004 317 328
131. C. Evereklioglu, M. Çekmen, and A. Özkiriş The pathophysiological significance of red blood cell nitric oxide concentrations in inflammatory Behçet's disease Mediators Inflamm 12 2003 255 256
132. C. Evereklioglu, Y. Cokkeser, and S. Doganay Audio-vestibular evaluation in patients with Behçet's syndrome J Laryngol Otol 115 2001 704 708
133. C. Evereklioglu, and H. Er Increased corneal thickness in active Behçet's disease Eur J Ophthalmol 12 2002 24 29
134. C. Evereklioglu, H. Er, Y. Türköz, and M. Çekmen Serum levels of TNF-a, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease Mediators Inflamm 11 2002 87 93
135. C. Evereklioglu, H.S. Inalöz, and N. Kirtak Serum leptin concentration is increased in patients with Behçet's syndrome and is correlated with disease activity Br J Dermatol 147 2002 331 336
136. C. Evereklioglu, E. Ozbek, and M. Cekmen Urinary nitric oxide levels are increased and correlated with plasma concentrations in patients with Behçet's disease: Is it a new urinary activity marker? Nephrology (Carlton) 8 2003 231 238
137. C. Evereklioglu, E. Ozbek, and H. Er Urinary adrenomedullin levels are increased and correlated with plasma concentrations in patients with Behçet's syndrome Int J Urol 9 2002 296 303
138. C. Evereklioglu, Y. Turkoz, and H. Er Increased nitric oxide production in patients with Behçet's disease: is it a new activity marker? J Am Acad Dermatol 46 2002 50 54
139. O. Fain, E. Mathieu, and E. Lachassinne Neonatal Behçet's disease Am J Med 98 1995 310 311
140. P.C. Falappone, F. Iannone, and C. Scioscia The treatment of recurrent uveitis with TNF-α inhibitors Reumatismo 56 2004 185 189
141. A.G. Fam, K.A. Siminovitch, S. Carette, and L. From Neonatal Behçet's syndrome in an infant of a mother with the disease Ann Rheum Dis 40 1981 509 512
142. S. Farah, A. Al-Shubaili, and A. Montaser Behçet's syndrome: a report of 41 patients with emphasis on neurological manifestations J Neurol Neurosurg Psychiatry 64 1998 382 384
143. A.J. Farrell, and D.R. Blake Nitric oxide Ann Rheum Dis 55 1996 7 20
144. M. Feki, H. Houman, and M. Ghannouchi Hyperhomocysteinaemia is associated with uveitis but not with deep venous thrombosis in Behçet's disease Clin Chem Lab Med 42 2004 1417 1423
145. E.J. Feron, A. Rothova, and P.M. van Hagen Interferon-α 2b for refractory ocular Behçet's disease Lancet 343 1994 1428
146. V. Fontes, L. Machet, and B. Huttenberger Recurrent aphthous stomatitis: treatment with colchicine. An open trial of 54 cases Ann Dermatol Venereol 129 2002 1365 1369
147. D.J. Forster General approach to uveitis patient and treatment strategies M. Yanoff J.S. Duker Ophthalmology 1999 Mosby London 1 6
148. M.A. Frassanito, R. Dammacco, P. Cafforio, and F. Dammacco Th1 polarization of the immune response in Behçet's disease: a putative pathogenic role of interleukin-12 Arthritis Rheum 42 1999 1967 1974
149. I. Fresko, H. Yazici, and M. Bayramiçli Effect of surgical cleaning of the skin on the pathergy phenomenon in Behçet's syndrome Ann Rheum Dis 52 1993 619 620
150. J. Freysdottir, S. Lau, and F. Fortune γ δ T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS) Clin Exp Immunol 118 1999 451 457
151. Y. Fujino, S. Joko, and K. Masuda Cyclosporin microemulsion preconcentrate treatment of patients with Behçet's disease Jpn J Ophthalmol 43 1999 318 326
152. O. Garcia Garcia, A. Vidaller Palacin, J. Munoz Sanchez, and G. Roca Linares Granulocyte-apheresis in ocular Behçet's disease resistant to medical treatment Arch Soc Esp Oftalmol 79 2004 335 340
153. R.K. George, C.C. Chan, S.M. Whitcup, and R.S. Nussenblatt Ocular immunopathology of Behçet's disease Surv Ophthalmol 42 1997 157 162
154. S. Georgiou, A. Monastirli, and E. Pasmatzi Efficacy and safety of systemic recombinant interferon-alpha in Behçet's disease J Intern Med 243 1998 367 372
155. J.V. Ghate, and J.L. Jorizzo Behçet's disease and complex aphthosis J Am Acad Dermatol 40 1999 1 18
156. F. Giansanti, M.L. Barbera, and G. Virgili Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behçet disease Eur J Ophthalmol 14 2004 445 448
157. B. Göker, and H. Göker Current therapy for Behçet's disease Am J Ther 9 2002 465 470
158. I. Goldberg Ocular inflammatory and steroid-induced glaucoma M. Yanoff J.S. Duker Ophthalmology 1999 Mosby London 1 6
159. M.F. Gonzalez-Escribano, M.R. Rodriguez, and F. Aguilar Lack of association of MICA transmembrane region polymorphism and Behçet's disease in Spain Tissue Antigens 54 1999 278 281
160. P.H. Goossens, R.J. Verburg, and F.C. Breedveld Remission of Behçet's syndrome with tumor necrosis factor α blocking therapy Ann Rheum Dis 60 2001 637
161. J.N. Gordon, and P.M. Goggin Thalidomide and its derivatives: emerging from the wilderness Postgrad Med J 79 2003 127 132
162. A.J. Greenwood, M.R. Stanford, and E.M. Graham The role of azathioprine in the management of retinal vasculitis Eye 12 1998 783 788
163. 206 Mol Biol Cell 9 1998 875 884
164. T.H. Guak, Y.I. Kim, S.M. Park, and J.S. Jim Paroxysmal focal dystonia in neuro-Behçet by a small ipsilateral thalamic lesion Eur Neurol 47 2002 183 184
165. S. Guermazi, M. Hamza, and K. Dellagi Protein S deficiency and antibodies to protein S in patients with Behçet's disease Thromb Res 86 1997 197 204
166. A. Gül Behçet's disease: an update on the pathogenesis Clin Exp Rheumatol 19 2001 6 12
167. A. Gül, A.B. Aslantaş, and T. Tekinay Procoagulant mutations and venous thrombosis in Behçet's disease Rheumatology 38 1999 1298 1299
168. A. Gül, A.H. Hajeer, and J. Worthington Linkage mapping of a novel susceptibility locus for Behçet's disease to chromosome 6p22-23 Arthritis Rheum 44 2001 2693 2696
169. A. Gül, M. Inanç, and L. Öcal Familial aggregation of Behçet's disease in Turkey Ann Rheum Dis 59 2000 622 625
170. S. Gulli, C. Arrigo, and L. Bocchino Remission of Behçet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report BMC Musculoskelet Disord 28 2003 19
171. K. Gündüz, G. Öztürk, and E.Y. Sözmen Erythrocyte superoxide dismutase, catalase activities and plasma nitrite and nitrate levels in patients with Behçet disease and recurrent aphthous stomatitis Clin Exp Dermatol 29 2004 176 179
172. H. Günen, C. Evereklioglu, and F. Koşar Thoracic involvement in Behçet's disease and its correlation with multiple parameters Lung 178 2000 161 170
173. A. Gurgey, G. Balta, and A. Boyvat Factor V Leiden mutation and PAI-1 gene 4G/5G genotype in thrombotic patients with Behçet's disease Blood Coagul Fibrinolysis 14 2003 121 124
174. A. Gürler, A. Boyvat, and U. Tursen Clinical manifestations of Behçet's disease: an analysis of 2147 patients Yonsei Med J 38 1997 423 427
175. Y. Hama, T. Kaji, and Y. Iwasaki Endovascular management of multiple arterial aneurysms in Behçet's disease Br J Radiol 77 2004 615 619
176. K.K. Hampton, M.A. Chamberlain, D.K. Menon, and J.A. Davies Coagulation and fibrinolytic activity in Behçet's disease Thromb Haemost 66 1991 292 294
177. V. Hamuryudan, T. Er, and E. Seyahi Pulmonary artery aneurysms in Behçet syndrome Am J Med 117 2004 867 870
178. V. Hamuryudan, C. Mat, and S. Saip Thalidomide in the treatment of the mucocutaneous lesions of the Behçet's syndrome: a randomized, double-blind, placebo-controlled trial Ann Intern Med 128 1998 443 450
179. V. Hamuryudan, F. Moral, and S. Yurdakul Systemic interferon α-2b treatment in Behçet's syndrome J Rheumatol 21 1994 1098 1100
180. V. Hamuryudan, Y. Özyazgan, and N. Hizli Azathioprine in Behçet's syndrome: effects on long-term prognosis Arthritis Rheum 40 1997 769 774
181. V. Hamuryudan, S. Yurdakul, and F. Moral Pulmonary artery aneurysms in Behçet's syndrome: a report of 24 cases Br J Rheumatol 33 1994 48 51
182. K. Hamzaoui, A. Hamzaoui, and F. Guemira Cytokine profile in Behçet's disease patients. Relationship with disease activity Scand J Rheumatol 31 2002 205 210
183. K. Hamzaoui, A. Hamzaoui, and F. Hentati Phenotype and functional profile of T cells expressing γδ receptor from patients with active Behçet's disease J Rheumatol 21 1994 2301 2306
184. K. Hamzaoui, A. Hamzaoui, L. Zakraoui, and A. Chabbou Expression of Bcl-2 in inflammatory sites from patients with active Behçet's disease Mediators Inflamm 8 1999 101 106
185. Han SW, Kim GW, Lee J,, et al. Successful treatment with stent angioplasty for Budd-Chiari syndrome in Behçet's disease. Rheumatol Int 25:234-7, 2005
186. G.J. Hankey, and J.W. Eikelboom Homocysteine and vascular disease Lancet 354 1999 407 413
187. M. Harman, M. Sayarlioglu, and H. Arslan Fibrosing mediastinitis and thrombosis of superior vena cava associated with Behçet's disease Eur J Radiol 48 2003 209 212
188. + subset J Exp Med 187 1998 1885 1892
189. P.V. Hassard, S.W. Binder, V. Nelson, and E.A. Nasiliauskas Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: a case report Gastroenterology 120 2001 995 999
190. H. Hassikou, W. Bono, and R. Bahiri Vascular involvement in Behçet's disease. Two case reports Jone Bone Spine 69 2002 416 418
191. G. Hatemi, H. Bahar, and S. Uysal The pustular skin lesions in Behçet's syndrome are not sterile Ann Rheum Dis 63 2004 1450 1452
192. G. Haugeberg, M. Velken, and V. Johnsen Successful treatment of genital ulcers with infliximab in Behçet's disease Ann Rheum Dis 63 2004 744 745
193. N. Hayasaki, M. Ito, and T. Suzuki Neutrophilic phlebitis is characteristic of intestinal Behçet's disease and simple ulcer syndrome Histopathology 45 2004 377 383
194. E. Haznedaroglu, Y. Karaaslan, and Y. Büyükaşik Selectin adhesion molecules in Behçet's disease Ann Rheum Dis 59 2000 61 63
195. I.C. Haznedaroglu, I. Çelik, and Y. Büyükaşik Haemostasis, thrombosis, and endothelium in Behçet's disease Acta Haematol 99 1998 236 237
196. I.C. Haznedaroglu, O. Özcebe, and I. Çelik Haemostatic markers of procoagulant imbalance in Behçet's disease Eur J Haematol 57 1996 107 108
197. S. Hegab, and S. Al-Mutawa Immunopathogenesis of Behçet's disease Clin Immunol 96 2000 174 186
198. T. Hemmen, A. Perez-Canto, and A. Distler IgA nephropathy in a patient with Behçet's syndrome: case report and review of literature Br J Rheumatol 36 1997 696 699
199. J. Hewitt, J.P. Escande, P. Lauret, and L. Perlemuter Criteria for diagnosis of Behçet's syndrome Bull Soc Fr Dermatol Syphiligr 76 1969 565 568
200. S. Hirohata, K. Isshi, and H. Oguchi Cerebrospinal fluid interleukin-6 in progressive Neuro-Behçet's syndrome Clin Immunol Immunopathol 82 1997 12 17
201. S. Hirohata, H. Suda, and T. Hashimoto Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behçet's disease J Neurol Sci 159 1998 181 185
202. T. Hirohata, M. Kuratsune, A. Nomura, and S. Jimi Prevalence of Behçet's syndrome in Hawaii. With particular reference to the comparison of the Japanese in Hawaii and Japan Hawaii Med J 34 1975 244 246
203. N. Hiller, S. Lieberman, and T. Chajek-Shaul Thoracic manifestations of Behçet disease at CT Radiographics 24 2004 801 808
204. T. Hirano Interleukin-6 and its relation to inflammation and disease Clin Immunol Immunopathol 62 1992 60 65
205. S. Hirohata, H. Oka, and Y. Mizushima Streptococcal-related antigens stimulate production of IL-6 and interferon-γ by T cells from patients with Behçet's disease Cell Immunol 140 1992 410 419
206. H. Houman, A. Hamzaoui, and I. Ben Ghorbal Abnormal expression of chemokine receptors in Behçet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations J Autoimmun 23 2004 267 273
207. H. Houman, A. Hamzaoui, and I. Ben Ghorbal Tc1/Tc2 ratio in the inflammatory process in patients with Behçet's disease Mediators Inflamm 13 2004 247 253
208. W. Hu, A. Hasan, and A. Wilson Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336-351 Eur J Immunol 28 1998 2444 2455
209. E.H. Hughes, and A.D. Dick The pathology and pathogenesis of retinal vasculitis Neuropathol Appl Neurobiol 29 2003 325 340
210. A. Iannaccone, C. Letizia, and S. Pazzaglia Plasma endothelin-1 concentrations in patients with retinal vein occlusions Br J Ophthalmol 82 1998 498 503
211. A. Idil, A. Gürler, and A. Boyvat The prevalence of Behçet's disease above the age of 10 years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey Ophthalmic Epidemiol 9 2002 325 331
212. U. Ikeda, M. Ikeda, S. Minota, and K. Shimada Homocysteine increases nitric oxide synthesis in cytokine-stimulated vascular smooth muscle cells Circulation 99 1999 1230 1235
213. Y. Imamura, M.S. Kurokawa, and H. Yoshikawa Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behçet's disease Clin Exp Immunol 139 2005 371 378
214. H.S. Inalöz, C. Evereklioglu, and B. Ünal The significance of immunohistochemistry in the skin pathergy reaction of patients with Behçet's syndrome J Eur Acad Dermatol Venereol 18 2004 56 61
215. International Study Group for Behçet's Disease: Criteria for diagnosis of Behçet's disease Lancet 335 1990 1078 1080
216. Z.H. Iscan, K.M. Vural, and M. Bayazit Compelling nature of arterial manifestations in Behçet disease J Vasc Surg 41 2005 53 58
217. K. Ishi, M. Kawai, and H. Kikuchi Low dose weekly methotrexate therapy for progressive neuro-Behçet's syndrome: a follow up study for 36 months Arthritis Rheum 41 1998 233
218. S. Ishida, C. Shiima, and G. Edagawa Serial MRI findings in a relapsing-remitting form of neuro-Behçet's disease: a case report Clin Imaging 28 2004 399 403
219. W.K. Jacyk Behçet's disease in South African blacks: report of five cases J Am Acad Dermatol 30 1994 869 873
220. A. Joseph, D. Raj, and H.S. Dua Infliximab in the treatment of refractory posterior uveitis Ophthalmology 110 2003 1449 1453
221. D. Kabelitz, D. Wesch, and T. Hinz γ δ T cells, their T cell receptor usage and role in human diseases Springer Semin Immunopathol 21 1999 55 75
222. V.G. Kaklamani, and P.G. Kaklamanis Treatment of Behçet's disease: an update Semin Arthritis Rheum 30 2001 299 312
223. V.G. Kaklamani, G. Vaiopoulos, and P.G. Kaklamanis Behçet's Disease Semin Arthritis Rheum 27 1998 197 217
224. V.G. Kaklamani, G. Vaiopoulos, N. Markomichelakis, and P. Kaklamanis Recurrent epididymoorchitis in patients with Behçet's disease J Urol 163 2000 487 489
225. F. Kaneko, N. Oyama, and A. Nishibu Streptococcal infection in the pathogenesis of Behçet's disease and clinical effects of minocycline on the disease symptoms Yonsei Med J 38 1997 444 454
226. S. Kaneko, N. Suzuki, and N. Yamashita Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behçet's disease (BD) in Japan Clin Exp Immunol 108 1997 204 212
227. T. Kanekura, A. Gushi, and M. Iwata Treatment of Behçet's disease with granulocyte and monocyte adsorption apheresis J Am Acad Dermatol 51 2004 83 87
228. J.J. Kanski Uveitis. Clinical ophthalmology, a systematic approach 2003 Butterworth-Heinemann London pp 271-308
229. M. Karaçorlu, B. Mudun, and H. Özdemir Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behçet disease Am J Ophthalmol 138 2004 289 291
230. Karasneh JA, Hajeer AH, Silman A,, et al. Polymorphisms in the endothelial nitric oxide synthase gene are associated with Behçet's disease. Rheumatology 44:614-7, 2005
231. J.A. Kari, V. Shah, and M.J. Dillon Behçet's disease in UK children: clinical features and treatment including thalidomide Rheumatology 40 2001 933 938
232. R. Karlidag, S. Ünal, and C. Evereklioglu Stressful life events, anxiety, depression and coping mechanisms in patients with Behçet's disease J Eur Acad Dermatol Venereol 17 2003 670 675
233. D.L. Kastner Behçet's disease W.J. Koopman Arthritis and allied conditions 1997 Williams & Wilkins Ohio 1291 1297
234. C.G. Katsiari, P.G. Theodossiadis, and P.G. Kaklamanis Successful long-term treatment of refractory Adamantiades-Behçet's disease (ABD) with infliximab: report of two patients Adv Exp Med Biol 528 2003 551 555
235. T.I. Kaya, H. Dur, U. Tursen, and A. Gürler Association of class I HLA antigens with the clinical manifestations of Turkish patients with Behçet's disease Clin Exp Dermatol 27 2002 498 501
236. H. Keino, J. Sakai, and K. Nishioka Clonally accumulating T cells in the anterior chamber of Behçet disease Am J Ophthalmol 130 2000 243 245
237. *5108, and lack of association of class II alleles with Behçet's disease in Italian patients Tissue Antigens 54 1999 565 571
238. A. Kibaroglu, E. Ekşioglu-Demiralp, T. Akoglu, and H. Direskeneli T and NK cell subset changes with microbial extracts and human HSP60-derived peptides in Behçet's disease Clin Exp Rheumatol 22 2004 59 63
239. D. Kidd, A. Steuer, A.M. Denman, and P. Rudge Neurological complications in Behçet's syndrome Brain 122 1999 2183 2194
240. B. Kim, and P.E. LeBoit Histopathologic features of erythema nodosum-like lesions in Behçet disease: a comparison with erythema nodosum focusing on the role of vasculitis Am J Dermatopathol 22 2000 379 390
241. C.Y. Kim, S.J. Kang, and S.J. Lee Opacification of a hydrophilic acrylic intraocular lens with exacerbation of Behçet's uveitis J Cataract Refract Surg 28 2002 1276 1278
242. E.H. Kim, J.W. Mok, and D.S. Bang Intercellular adhesion molecule-1 polymorphism in Korean patients with Behçet's disease J Korean Med Sci 18 2003 415 418
243. H.A. Kim, K.W. Choi, and Y.W. Song Arthropathy in Behçet's disease Scand J Rheumatol 26 1997 125 129
244. J.U. Kim, H.K. Chang, and S.S. Lee Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease and rheumatic diseases with vasculitis Ann Rheum Dis 62 2003 1083 1087
245. S. Kiraz, I. Ertenli, M. Benekli, and M. Calgüneri Parvovirus B19 infection in Behçet's disease Clin Exp Rheumatol 14 1996 71 73
246. S. Kiraz, I. Ertenli, and M. Çalgüneri Interactions of nitric oxide and superoxide dismutase in Behçet's disease Clin Exp Rheumatol 19 2001 25 29
247. S. Kiraz, I. Ertenli, and I.C. Haznedaroglu Pathological haemostasis and "prothrombotic state" in Behçet's disease Thromb Res 105 2002 125 133
248. J.D. Klausner, V.H. Freedman, and G. Kaplan Thalidomide as an anti-TNF-α inhibitor: implications for clinical use Clin Immunol Immunopathol 81 1996 219 223
249. M. Kobayashi, M. Ito, and A. Nakagawa Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Behçet disease Histopathology 36 2000 362 371
250. N. Koçer, C. Islak, and A. Siva CNS involvement in neuro-Behçet syndrome: an MR study AJNR Am J Neuroradiol 20 1999 1015 1024
251. T. Koga, T. Yano, and Y. Ichikawa Pulmonary infiltrates recovered by FK506 in a patient with Behçet's disease Chest 104 1993 309 311
252. I. Kökçam, and M. Naziroglu Effects of vitamin E supplementation on blood antioxidants levels in patients with Behçet's disease Clin Biochem 35 2002 633 639
253. I. Kone-Paut, I. Geisler, and B. Wechsler Familial aggregation in Behçet's disease: high frequency in siblings and parents of pediatric probands J Pediatr 135 1999 89 93
254. I. Kone-Paut, S. Yurdakul, and S.A. Bahabri Clinical features of Behçet's disease in children. an international collaborative study of 86 cases J Pediatr 132 1998 721 725
255. U. Korman, M. Cantaşdemir, and S. Kurugoglu Enteroclysis findings of intestinal Behçet's disease: a comparative study with Chron disease Abdom Imaging 28 2003 308 312
256. K. Köse, P. Dogan, M. Aşçioglu, and O. Aşçioglu In vitro antioxidant effect of Ginkgo biloba extract (EGb 761) on lipoperoxidation induced by hydrogen peroxide in erythrocytes of Behçet's patients Jpn J Pharmacol 75 1997 253 258
257. K. Köse, C. Yazici, and Ö Asçioglu The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behçet's disease Clin Biochem 34 2001 125 129
258. K. Köse, C. Yazici, and N. Çambay Lipid peroxidation and erythrocyte antioxidant enzymes in patients with Behçet's disease Tohoku J Exp Med 197 2002 9 16
259. S. Kotake, K. Higashi, and K. Yoshikawa Central nervous system symptoms in patients with Behçet's disease receiving cyclosporine therapy Ophthalmology 106 1999 586 589
260. I. Kötter, H. Dürk, and A. Eckstein Erosive arthritis and posterior uveitis in Behçet's disease. Treatment with interferon α and interferon γ Clin Exp Rheumatol 14 1996 113 115
261. I. Kötter, A.K. Eckstein, N. Stubiger, and M. Zierhut Treatment of ocular symptoms of Behçet's disease with interferon-α2a: a pilot study Br J Ophthalmol 82 1998 488 494
262. I. Kötter, R. Vonthein, and C.A. Muller Behçet's disease in patients of German and Turkish origin living in Germany: a comparative analysis J Rheumatol 31 2004 133 139
263. I. Kötter, R. Vonthein, and M. Zierhut Differential efficacy of human recombinant interferon-α2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trial Semin Arthritis Rheum 33 2004 311 319
264. I. Kötter, M. Zierhut, and A.K. Eckstein Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis Br J Ophthalmol 87 2003 423 431
265. M.T. Kram, L.D. May, S. Goodman, and S. Molinas Behçet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case Dis Colon Rectum 46 2003 118 121
266. M. Kramer, R. Ehrlich, and M. Snir Intravitreal injections of triamcinolone acetonide for severe vitritis in patients with incomplete Behçet's disease Am J Ophthalmol 138 2004 666 668
267. I. Krause, Y. Monselise, G. Milo, and A. Weinberger Anti-Saccharomyces cerevisiae antibodies - a novel serologic marker for Behçet's disease Clin Exp Rheumatol 20 2002 21 24
268. L. Krause Vitrectomy and trabeculectomy combined with interferon alpha treatment in Adamantiades-Behçet's disease: a case report Graefes Arch Clin Exp Ophthalmol 241 2003 871 874
269. E. Kural-Seyahi, I. Fresko, and N. Seyahi The long-term mortality and morbidity of Behçet's syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center Medicine 82 2003 60 76
270. S. Kurhan-Yavuz, H. Direskeneli, and N. Bozkurt Anti-MHC autoimmunity in Behçet's disease: T cell responses to an HLA-B derived peptide cross-reactive with retinal-S antigen in patients with uveitis Clin Exp Immunol 120 2000 162 166
271. R. Kuriwaka, M. Kunishige, and H. Nakahira Neuro- Behçet's disease with chorea after remission of intestinal Behçet's disease Clin Rheumatol 23 2004 364 367
272. U. Kurumety, A.A. Okada, M. Usui, and N.A. Rao Behçet's syndrome M. Yanoff J.S. Duker Ophthalmology 1999 Mosby London 1 4
273. S. Kutlay, S. Civriz, and A. Ensari Development of amyloidosis in Behçet's syndrome with isolated mucocutaneous involvement Rheumatol Int 24 2004 37 39
274. G. Lawton, B.B. Bhakta, M.A. Chamberlain, and A. Tennant The Behçet's disease activity index Rheumatology 43 2004 73 78
275. M. Lazarczyk, T. Grzela, and G. Korczak-Kowalska Pentoxifylline inhibits perforin-dependent natural cytotoxicity in vitro Oncol Rep 9 2002 423 426
276. K.H. Lee, H.S. Chung, and H.S. Kim Human α-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease Arthritis Rheum 48 2003 2025 2035
277. L.A. Lee Behçet's disease Semin Cutan Med Surg 20 2001 53 57
278. S. Lee, D. Bang, and Y.H. Cho Polymerase chain reaction reveals Herpes simplex virus DNA in saliva of patients with Behçet's disease Arch Dermatol Res 288 1996 179 183
279. Y.J. Lee, S.W. Kang, and J.I. Yang Coagulation parameters and plasma total homocysteine levels in Behçet's disease Thromb Res 106 2002 19 24
280. T. Lehner The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease Int Rev Immunol 14 1997 21 32
281. T. Lehner, E. Lavery, and R. Smith Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behçet's syndrome Infect Immun 59 1991 1434 1441
282. M. Leiba, U. Seligsohn, and Y. Sidi Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease Ann Rheum Dis 63 2004 1445 1449
283. B. Li, P. Yang, and H. Zhou T-bet expression is upregulated in active Behçet's disease Br J Ophthalmol 87 2003 1264 1267
284. G. Licata, A. Pinto, and A. Tuttolomondo Anti-tumour necrosis factor α monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome Ann Rheum Dis 62 2003 280 281
285. C.M. Lockwood, G. Hale, H. Waldman, and D.R. Jayne Remission induction in Behçet's disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H Rheumatology 42 2003 1539 1544
286. R.N. Maini, and P.C. Taylor Anti-cytokine therapy for rheumatoid arthritis Ann Rev Med 51 2000 207 229
287. A.M. Mansour Infliximab treatment of posterior uveitis Ophthalmology 111 2004 197 198
288. C. Mantaş, H. Direskeneli, E. Ekşioglu-Demiralp, and T. Akoǧlu Serum levels of Th2 cytokines IL-4 and IL-10 in Behçet's disease J Rheumatol 26 1999 510 512
289. M.L. Marin, C.R. Savioli, and J.H. Yamamoto MICA polymorphism in a sample of the Sao Paulo population, Brazil Eur J Immunogenet 31 2004 63 71
290. N.N. Markomichelakis, P.G. Theodossiadis, and E. Pantelia Infliximab for chronic cystoid macular edema associated with uveitis Am J Ophthalmol 138 2004 648 650
291. S. Marsal, C. Falga, and C.P. Simeon Behçet's disease and pregnancy relationship study Br J Rheumatol 36 1997 234 238
292. S.E. Marshall Behçet's disease Best Pract Res Clin Rheumatol 18 2004 291 311
293. R.M. Mason, and C.G. Barnes Behçet's syndrome with arthritis Ann Rheum Dis 28 1969 95 103
294. K. Masuda, A. Nakajima, and A. Urayama Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease Lancet 1 1989 1093 1096
295. T. Matsui, M. Kurokawa, and T. Kobata Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases J Immunol 162 1999 4328 4335
296. T. Matsui, M. Otsuka, and K. Maenaka Detection of autoantibodies to killer immunoglobulin-like receptors using recombinant fusion proteins for two killer immunoglobulin-like receptors in patients with systemic autoimmune diseases Arthritis Rheum 44 2001 384 388
297. T. Matsuo, M. Takahashi, and Y. Inoue Ocular attacks after phacoemulsification and intraocular lens in patients with Behçet disease Ophthalmologica 215 2001 179 182
298. E.V. Maytin Heat shock proteins and molecular chaperones: implications for adaptive responses in the skin J Invest Dermatol 104 1995 448 455
299. J.L. Mege, N. Dilşen, and V. Sanguedolce Overproduction of monocyte derived tumor necrosis factor α, interleukin (IL)-6, IL-8 and increased neutrophil superoxide generation in Behçet's disease: a comparative study with familial Mediterranean fever and healthy subjects J Rheumatol 20 1993 1544 1549
300. Melikoglu M, Altiparmak MR, Fresko I,, et al. A reappraisal of amyloidoss in Behçet's syndrome. Rheumatology (Oxford) 40:212-5, 2001
301. M. Melikoglu, I. Fresko, and C. Mat Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study J Rheumatol 32 2005 98 105
302. M. Melikoglu, Y. Özyazgan, and I. Fresko The response of treatment resistant uveitis in Behçet's syndrome (BS) to a TNF-α blocker, etanercept: an open study Arthritis Rheum 46 2002 181
303. J.B. Michelson, and F.V. Chisari Behçet's disease Surv Ophthalmol 26 1982 190 203
304. S.M. Mirsattari, G.J. McGinn, and W.C. Halliday Neuro-Behçet disease with predominant involvement of the brainstem Neurology 27 2004 382 384
305. Mishima H, Masuda K, Shimada S,, et al. Plasminogen activator activity in patients with Behçet's sydrome. Arch Ophthalmol 103:935-6, 1985
306. M. Misumi, E. Hagiwara, and M. Tekeno Cytokine production profile in patients with Behçet's disease treated with infliximab Cytokine 24 2003 210 218
307. N. Mizuki, H. Inoko, and S. Ohno Pathogenic gene responsible for the predisposition of Behçet's disease Int Rev Immunol 14 1997 33 48
308. N. Mizuki, M. Ota, and M. Kimura Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet's disease Proc Natl Acad Sci USA 94 1997 1298 1303
309. Y. Mizushima Behçet's disease Curr Opin Rheumatol 3 1991 32 35
310. M. Mochizuki Immunotherapy for Behçet's disease Intern Rev Immunol 14 1997 49 66
311. M. Mochizuki, K. Masuda, and T. Sakane A clinical trial of FK506 in refractory uveitis Am J Ophthalmol 115 1993 763 769
312. M. Mochizuki, N. Suzuki, and M. Takeno Fine antigen specificity of human γ δ T cell lines (V gamma 9+) established by repetitive stimulation with a serotype (KTH-1) of a gram-positive bacterium, Streptococcus sanguis Eur J Immunol 24 1994 1536 1543
313. N. Mogulkoç, M.I. Burgess, and P.W. Bishop Intracardiac thrombus in Behçet's disease: a systematic review Chest 118 2000 479 487
314. +) patient with Behçet disease and rapidly progressive glomerulonephritis Clin Nephrol 61 2004 357 359
315. S. Molet, K. Furukawa, and A. Maghazechi Chemokine- and cytokine-induced expression of endothelin 1 and endothelin-converting enzyme 1 in endothelial cells J Allergy Clin Immunol 105 2000 333 338
316. N. Molinari, I. Kone-Paut, and R. Manna Identification of an autosomal recessive mode of inheritance in paediatric Behçet's families by segregation analysis Am J Med Genet 122 2003 115 118
317. R. Monastero, C. Camarda, and C. Pipia Cognitive impairment in Behçet's disease patients without overt neurological involvement J Neurol Sci 220 2004 99 104
318. F. Mor, A. Weinberger, and I.R. Cohen Identification of α-tropomyosin as a target self-antigen in Behçet's syndrome Eur J Immunol 32 2002 356 365
319. A.L. Moreira, E.P. Sampaio, and A. Zmuidzinas Thalidomide exerts its inhibitory action on tumor necrosis factor α by enhancing mRNA degradation J Exp Med 177 1993 1675 1680
320. S. Morelli, C. Perrone, and L. Ferrante Cardiac involvement in Behçet's disease Cardiology 88 1997 513 517
321. N. Morimoto, Y. Okita, and Y. Tsuji Inferior mesenteric artery aneurysm in Behçet syndrome J Vasc Surg 38 2003 1434 1436
322. D.S. Morris, M.P. Gavin, and R.D. Sturrock The effect of anti-tumour necrosis factor α (infliximab) on sight-threatening uveitis in a patient with Behçet's disease Adv Exp Med Biol 528 2003 557 559
323. S.P. Morrissey, D.H. Miller, and R. Hermaszewski Magnetic resonance imaging of the central nervous system in Behçet's disease Eur Neurol 33 1993 287 293
324. A.G. Moses, N. Dowidar, and B. Holloway Leptin and its relation to weight loss, ob gene expression and the acute-phase response in surgical patients Br J Surg 88 2001 588 593
325. H. Moshage Nitric oxide determinations: Much ado about NO-thing? Clin Chem 43 1997 553 556
326. B.A. Mudun, A. Ergen, and S.U. Ipçioglu Short-term chlorambucil for refractory uveitis in Behçet's disease Ocul Immunol Inflamm 9 2001 219 229
327. G. Mumcu, T. Ergün, and Y. Elbir Clinical and immunological effects of azithromycin in Behçet's disease J Oral Pathol Med 34 2005 13 16
328. S. Munoz-Fernandez, V. Hidalgo, and J. Fernandez-Melon Effect of infliximab on threatening panuveitis in Behçet's disease Lancet 358 2001 1644
329. T. Mussack, N. Landauer, and R. Ladurner Successful treatment of cervical esophageal perforation in Behçet's disease with drainage operation and infliximab Am J Gastroenterol 98 2003 703 704
330. H. Nagafuchi, M. Takeno, and H. Yoshikawa Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behçet's disease Clin Exp Immunol 139 2005 363 370
331. M. Naganuma, Y. Iwao, and K. Kashiwagi A case of Behçet's disease accompanied by colitis with longitudinal ulcers and granuloma J Gastroenterol Hepatol 17 2002 105 108
332. S. Navarro, J.M. Ricart, and P. Medina Activated protein C levels in Behçet's disease and risk of venous thrombosis Br J Haematol 126 2004 550 556
333. G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak Vascular endothelial growth factor (VEGF) and its receptors FASEB J 13 1999 9 22
334. J.C. Nichols, A. Ince, L. Akduman, and E.S. Mann Interferon-a2a treatment of neuro-Behçet's disease J Neuroophthalmol 21 2001 109 111
335. T. Nishida, and N. Mizuki Lack of association of interleukin-12 p40 gene (IL12B) polymorphism with Behçet 's disease in the Japanese population J Dermatol Sci 34 2004 112 114
336. K. Nishiura, S. Kotake, A. Ichiishi, and H. Matsuda Familial occurrence of Behçet's disease Jpn J Ophthalmol 40 1996 255 259
337. M. Nishiyama, K. Nakae, and T. Kuriyama A study among related pairs of Japanese patients with familial Behçet's disease: group comparisons by interval of disease onsets J Rheumatol 29 2002 743 747
338. M. Nishiyama, K. Nakae, and T. Umehara A study of familial occurrence of Behçet's disease with and without ocular lesions Jpn J Ophthalmol 45 2001 313 316
339. Y. Nomura, N. Kitteringham, and K. Shiba Use of the highly sensitive PCR method to detect the Herpes simplex virus type 1 genome and its expression in samples from Behçet disease patients J Med Dent Sci 45 1998 51 58
340. T. Noyan, I. Şahin, M.R. Şekeroglu, and H. Dülger The serum vitamin C levels in Behçet's disease Yonsei Med J 44 2003 771 778
341. R.B. Nussenblatt Uveitis in Behçet's disease Int Rev Immunol 14 1997 67 79
342. R.B. Nussenblatt, I. Gery, and H.L. Weiner Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial Am J Ophthalmol 123 1997 583 592
343. R.B. Nussenblatt, S.M. Whitcup, and M.D. de Smet Intraocular inflammatory disease (uveitis) and the use of oral tolerance: a status report Ann NY Acad Sci 778 1996 325 337
344. J.D. O'Duffy Vasculitis in Behçet's disease Rheum Dis Clin North Am 16 1990 423 431
345. J.D. O'Duffy, K. Calamia, and S. Cohen Interferon α treatment of Behçet's disease J Rheumatol 25 1998 1938 1944
346. J.D. O'Duffy, and N.P. Goldstein Neurologic involvement in seven patients with Behçet's disease Am J Med 61 1976 170 178
347. J.D. O'Duffy, D.M. Robertson, and N.P. Goldstein Chlorambucil in the treatment of uveitis and meningoencephalitis of Behçet's disease Am J Med 76 1984 75 84
348. S. Ohno, S. Nakamura, and S. Hori Efficacy, safety and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis J Rheumatol 31 2004 1362 1368
349. O. Öktem-Tanor, B. Baykan-Kurt, and I.H. Gurvit Neuropsychological follow-up of 12 patients with neuro-Behçet disease J Neurol 246 1999 113 119
350. M. Önder, M. Bozkurt, M.A. Gürer, and A. Gülekon Natural cellular cytotoxicity in Behçet's disease J Dermatol 21 1994 239 243
351. M. Önder, and M.A. Gürer Behçet's disease: an enigmatic vasculitis Clin Dermatol 17 1999 571 576
352. M. Önder, and M.A. Gürer The multiple faces of Behçet's disease and its aetiological factors J Eur Acad Dermatol Venereol 15 2000 126 136
353. A. Örem, G. Cimşit, and O. Deger Autoantibodies against oxidatively modified low-density lipoprotein in patients with Behçet's disease Dermatology 198 1999 243 246
354. A. Örem, H. Efe, and O. Deger Relationship between lipid peroxidation and disease activity in patients with Behçet's disease J Dermatol Sci 16 1997 11 16
355. A. Örem, B. Vanizor, and G. Cimşit Decreased nitric oxide production in patients with Behçet's disease Dermatology 198 1999 33 36
356. N.N. Osborne, N.L. Barnett, and A.J. Herrera NADPH diaphorase localization and nitric oxide synthase activity in the retina and anterior uvea of the rabbit eye Brain Res 610 1993 194 198
357. M. Ota, N. Mizuki, and Y. Katsuyama The critical region for Behçet disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping Am J Hum Genet 64 1999 1406 1410
358. D. Özatli, N. Sayinalp, and Y. Büyükaşik Unchanged global fibrinolytic capacity despite increased factor VIIa activity in Behçet's disease: evidence of a prethrombotic state Rheumatol Int 21 2002 137 140
359. R. Özdemir, I. Barutçu, and A.T. Sezgin Vascular endothelial function and plasma homocysteine levels in Behçet's disease Am J Cardiol 94 2004 522 525
360. S. Özen Vasculopathy, Behçet's syndrome, and familial Mediterranean fever Curr Opin Rheumatol 11 1999 393 398
361. C. Özge, M. Çalikoglu, and A. Yildiz Bilateral pulmonary artery aneurysms with protein C and protein S deficiency in a patient with Behçet's disease Scand J Rheumatol 33 2004 52 54
362. M.O. Öztaş, M. Önder, and M.A. Gürer Serum interleukin 18 and tumour necrosis factor-α levels are increased in Behçet's disease Clin Exp Dermatol 30 2005 61 63
363. M.A. Öztürk, I. Ertenli, and S. Kiraz Plasminogen activator inhibitor-1 as a link between pathological fibrinolysis and arthritis of Behçet's disease Rheumatol Int 24 2004 98 102
364. M.A. Öztürk, Z. Özbalkan, and A.M. Onat Decreased protein Z concentrations complicating the hypercoagulable state of Behçet's disease Clin Appl Thromb Hemost 9 2003 259 263
365. Y. Özyazgan, S. Yurdakul, and H. Yazici Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial Br J Ophthalmol 76 1992 241 243
366. J.H. Park Clinical analysis of Behçet disease: arthritic manifestations in Behçet disease may present as seronegative rheumatoid arthritis or palindromic rheumatism Korean J Intern Med 14 1999 66 72
367. K.S. Park, H.J. Ko, and C.H. Yoon Magnetic resonance imaging and proton magnetic resonance spectroscopy in neuro- Behçet's disease Clin Exp Rheumatol 22 2004 561 567
368. D.J. Parks, M.K. Cheung, C.C. Chan, and F.G. Roberge The role of nitric oxide in uveitis Arch Ophthalmol 112 1994 544 546
369. P. Picco, B. Porfirio, and M. Gattorno MICA gene polymorphism in an Italian paediatric series of juvenile Behçet's disease Int J Mol Med 10 2002 575 578
370. M.C. Pickering, and D.O. Haskard Behçet's syndrome J R Coll Physicians Lond 34 2000 169 177
371. I. Pirim, M. Atasoy, and M. Ikbal HLA class I and class II genotyping in patients with Behçet's disease: a regional study of eastern part of Turkey Tissue Antigens 64 2004 293 297
372. G. Polat, G. Eskandari, and T.I. Kaya Association of the platelet glycoprotein Ia C870T/G873A gene polymorphism and thrombosis in Behçet's patients Haematologia 32 2002 121 128
373. W. Poon, D.H. Verity, and G.L. Larkin Behçet's disease in patients of west African and Afro-Caribbean origin Br J Ophthalmol 87 2003 876 878
374. K. Probst, R. Fijnheer, and A. Rothova Endothelial cell activation and hypercoagulability in ocular Behçet's disease Am J Ophthalmol 137 2004 850 857
375. A. Ramsay, and S. Lightman Hypopyon uveitis Surv Ophthalmol 46 2001 1 18
376. R. Rapelanoro, P. Lamarque, and L. Rousseau Epididymitis in Behçet disease Presse Med 26 1997 1385
377. S. Raziuddin, A. al-Dalaan, and S. Bahabri Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern J Rheumatol 25 1998 329 333
378. J.B. Reed, L.S. Morse, and I.R. Schwab High-dose intravenous pulse methylprednisolone hemisuccinate in acute Behçet retinitis Am J Ophthalmol 125 1998 409 411
379. L.P. Robertson, and P. Hickling Treatment of recalcitrant orogenital ulceration of Behçet's syndrome with Infliximab Rheumatology 40 2001 473 474
380. S. Romagnani Biology of human TH1 and TH2 cells J Clin Immunol 15 1995 121 129
381. J.T. Rosenbaum Blind insight: eyeing anti-tumor necrosis factor treatment in uveitis associated with Behçet's disease J Rheumatol 31 2004 1241 1243
382. M. Rozenbaum, I. Rosner, and E. Portnoy Remission of Behçet's syndrome with TNF-a blocking treatment Ann Rheum Dis 61 2002 283 284
383. D. Saba, H. Saricaoglu, and A.S. Bayram Arterial lesions in Behçet's disease Vasa 32 2003 75 81
384. A. Saenz, M. Ausejo, and B. Shea Pharmacotherapy for Behçet's syndrome (Cochrane Review) The Cochrane Library, Issue 3 2004 John Wiley & Sons, Ltd Chichester, UK
385. K. Saglam, A.F. Serçe, and M.I. Yilmaz Trace elements and antioxidant enzymes in Behçet's disease Rheumatol Int 22 2002 93 96
386. S. Şahin, T. Akoglu, and H. Direskeneli Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease Ann Rheum Dis 55 1996 128 133
387. S. Şahin, R. Lawrence, and H. Direskeneli Monocyte activity in Behçet's disease Br J Rheumatol 35 1996 424 429
388. I. Şahin, T. Noyan, and E. Karaman Mild renal injury in Behçet's disease Ren Fail 26 2004 55 57
389. M. Sakamoto, K. Akazawa, and Y. Nishioka Prognostic factors of vision in patients with Behçet's disease Ophthalmology 102 1995 317 321
390. T. Sakane, and M. Takeno Novel approaches to Behçet's disease Exp Opin Invest Drugs 9 2000 1993 2005
391. T. Sakane, M. Takeno, N. Suzuki, and G. Inaba Behçet's disease N Engl J Med 341 1999 1284 1291
392. C. Salvarani, L. Boiardi, and B. Casali Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease J Rheumatol 29 2002 535 540
393. C. Salvarani, L. Boiardi, and B. Casali Vascular endothelial growth factor gene polymorphisms in Behçet's disease J Rheumatol 31 2004 1785 1789
394. B. Sancak, M. Önder, and M.O. Öztaş Nitric oxide levels in Behçet's disease J Eur Acad Dermatol Venereol 17 2003 7 9
395. *1602: a new susceptibility marker of Behçet's disease in southern Spain Tissue Antigens 51 1998 111 114
396. V. Saravanan, and J. Hamilton Advances in the treatment of rheumatoid arthritis: old versus new therapies Expert Opin Pharmacother 3 2002 845 856
397. R.A. Sari, A. Kiziltunç, and S. Taysy Levels of soluble E-selectin in patients with active Behçet's disease Clin Rheumatol 24 2005 55 59
398. H. Sarwar, H. McGrath Jr., and L.R. Espinoza Successful treatment of long-standing neuro-Behçet's disease with infliximab J Rheumatol 32 2005 181 183
399. F.T. Saulsbury, and J.A. Mann Treatment with infliximab for a child with Behçet's disease Arthritis Rheum 49 2003 599 600
400. P. Scapini, J.A. Lapinet-Vera, and S. Gasperini The neutrophil as a cellular source of chemokines Immunol Rev 177 2000 195 203
401. P. Scheid, A. Bohadana, and Y. Martinet Nicotine patches for aphthous ulcers due to Behçet's syndrome New Engl J Med 343 2000 1816 1817
402. N. Scheinfeld Off-label uses and side effects of infliximab J Drugs Dermatol 3 2004 273 284
403. M. Schirmer, K.T. Calamia, and J.D. O'Duffy Is there a place for large vessel disease in the diagnostic criteria of Behçet's disease? J Rheumatol 26 1999 2511 2512
404. + T helper type 2 cells J Exp Med 181 1995 5 7
405. N. Seider, I. Beiran, J. Scharf, and B. Miller Intravenous immuno globulin therapy for resistant ocular Behçet's disease Br J Ophthalmol 85 2001 1287 1288
406. N. Şengül, S. Demirer, and M.A. Yerdel Comparison of coagulation parameters for healthy subjects and Behçet disease patients with and without vascular involvement World J Surg 24 2001 1584 1588
407. M.U. Şentürk, U.K. Şentürk, and P.Y. Başak Serum and skin nitrite levels in patients with Behçet's disease J Eur Acad Dermatol Venereol 17 2003 614 615
408. T. Şentürk, O. Aydintug, and I. Kuzu Adhesion molecule expression in erythema nodosum-like lesions in Behçet's disease. A histopathological and immunohistochemical study Rheumatol Int 18 1998 51 57
409. P. Serdaroglu Behçet's disease and the nervous system J Neurol 245 1998 197 205
410. P.P. Sfikakis Behçet's disease: a new target for anti-tumour necrosis factor treatment Ann Rheum Dis 61 2002 51 53
411. P.P. Sfikakis, P.H. Kaklamanis, and A. Elezoglou Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease Ann Intern Med 140 2004 404 406
412. P.P. Sfikakis, P.G. Theodossiadis, and C.G. Katsiari Effect of infliximab on sight-threatening panuveitis in Behçet's disease Lancet 358 2001 295 296
413. K.E. Sharquie, R.A. Najim, and A.R. Abu-Raghif Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross- over study J Dermatol 29 2002 267 279
414. L.P. Shek, Y.S. Lee, B.W. Lee, and T.S. Lehman Thalidomide responsiveness in an infant with Behçet's syndrome Pediatrics 103 1999 1295 1297
415. L.P. Shek, and D.L. Lim Thalidomide in Behçet's disease Biomed Pharmacother 56 2002 31 35
416. R. Shenoy Conjunctival ulcer: mucocutaneous or ocular manifestation of Behçet's disease? A case report Eur J Ophthalmol 12 2002 435 436
417. S.J. Sheu, and C.A. Yang Macular hole in Behçet's disease Kaohsiung J Med Sci 20 2004 558 562
418. T. Shimizu Behçet's disease Jpn J Ophthalmol 18 1974 291 294
419. H. Şimşek, S. Dündar, and H. Telatar Treatment of Behçet's disease with indomethacin Int J Dermatol 30 1991 54 57
420. A. Siva, A. Altintaş, and S. Saip Behçet's syndrome and the nervous system Curr Opin Neurol 17 2004 347 357
421. A. Siva, O.H. Kantarci, and S. Saip Behçet's disease: diagnostic and prognostic aspects of neurological involvement J Neurol 248 2001 95 103
422. C.M. Sloper, R.J. Powell, and H.S. Dua Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine Ophthalmology 106 1999 723 728
423. S. Sohn, E.S. Lee, D. Bang, and S. Lee Behçet's disease-like symptoms induced by the Herpes simplex virus in ICR mice Eur J Dermatol 8 1998 21 23
424. M. Sönmezoglu, E. Derviş, S. Badur, and O.S. Yenen Examination of the relationship between the hepatitis C virus and Behçet's disease J Dermatol 31 2004 442 443
425. K.H. Sonoda, H. Enaida, and A. Ueno Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study Br J Ophthalmol 87 2003 1010 1014
426. K.H. Sonoda, S. Inaba, and A. Ariyama Therapeutic neutrophil apheresis in patients with ocular Behçet disease Arch Ophthalmol 123 2005 267 269
427. M. Soy, E. Erken, K. Konca, and S. Özbek Smoking and Behçet's disease Clin Rheumatol 19 2000 508 509
428. M. Soylu, N. Demircan, and A. Pelit Pars plana vitrectomy in ocular Behçet's disease Int Ophthalmol 24 2001 219 223
429. D.J. Spalton Intraocular inflammation D.J. Spalton R.A. Hitchings P.A. Hunter Atlas of clinical ophthalmology 1994 Mosby London 1 32
430. M.R. Stanford, E. Kasp, and R. Whiston Heat shock protein peptides reactive in patients with Behçet's disease are uveitogenic in Lewis rats Clin Exp Immunol 97 1994 226 231
431. A.C. Stark, B. Bhakta, and M.A. Chamberlain Life-threatening transient neonatal Behçet's disease Br J Rheumatol 36 1997 700 702
432. N. Sugi-Ikai, M. Nakazawa, and S. Nakamura Increased frequencies of interleukin-2 and interferon-γ-producing T cells in patients with active Behçet's disease Invest Ophthalmol Vis Sci 39 1998 996 1004
433. Y. Süllü, I. Öge, and D. Erkan Cyclosporine-A therapy in severe uveitis of Behçet's disease Acta Ophthalmol Scand 76 1998 96 99
434. Y. Süllü, N. Şentürk, and L. Yildiz Bcl-2 expression in skin pathergy reaction of Behçet's disease Dermatology 202 2001 90 93
435. N. Suzuki, S. Kaneko, and M. Ichino In vivo mechanisms for the inhibition of T lymphocyte activation by long-term therapy with tacrolimus (FK-506): experience in patients with Behçet's disease Arthritis Rheum 40 1997 1157 1167
436. H. Takagi, G.L. King, N. Ferrara, and L.P. Aiello Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells Invest Ophthalmol Vis Sci 37 1996 1311 1321
437. M. Takeno, A. Kariyone, and N. Yamashita Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice Arthritis Rheum 38 1995 426 433
438. T. Tanaka, J. Suzuki, N. Yamakawa, and M. Usui Molecular biological analysis of retinal and streptococcal heat-shock protein 60 Jpn J Ophthalmol 44 2000 692
439. T. Tanaka, N. Yamakawa, and N. Koike Behçet's disease and antibody titers to various heat-shock protein 60s Ocul Immunol Inflamm 7 1999 69 74
440. T. Tanaka, N. Yamakawa, and H. Yamaguchi Common antigenicity between Yersinia enterocolitica-derived heat-shock protein and the retina, and its role in uveitis Ophthalmic Res 28 1996 284 288
441. N. Tanriverdi, I. Taşkintuna, and C. Duru Health-related quality of life in Behçet patients with ocular involvement Jpn J Ophthalmol 47 2003 85 92
442. B. Taşçi, H. Direskeneli, and P. Serdaroglu Humoral immune response to mycobacterial heat shock protein (HSP) 65 in the cerebrospinal fluid of neuro-Behçet patients Clin Exp Immunol 113 1998 100 104
443. C. Tataroglu, U. Tursen, O. Ünal, and T.I. Kaya Long-latency reflexes in patients with Behçet's disease J Neurol Sci 220 2004 67 71
444. O. Tekeli, and O. Özdemir Heidelberg retina tomograph in ocular Behçet's disease Eye 18 2004 143 146
445. The Behçet's Disease Research Committee of Japan skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behçet's disease: a multicenter study J Rheumatol 16 1989 506 511
446. C. Thomas-Golbanov, and S. Sridharan Novel therapies in vasculitis Exp Opin Invest Drug 10 2001 1279 1289
447. S.R. Thurau, M. Diedrichs-Mohring, and H. Fricke Oral tolerance with an HLA-peptide mimicking retinal autoantigen as a treatment of autoimmune uveitis Immunol Lett 68 1999 205 212
448. M.J. Tocci, D.A. Matkovich, and K.A. Collier The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes J Immunol 143 1989 718 726
449. K. Toda, Y. Shiratori, and M. Yasuda Therapeutic effect of intraarterial prednisolone injection in severe intestinal Behçet's disease J Gastroenterol 37 2002 844 848
450. A. Tohme, N. Aoun, B. El-Rassi, and E. Ghayad Vascular manifestations of Behçet's disease. Eighteen cases among 140 patients Joint Bone Spine 70 2003 384 389
451. A. Tohme, F. Haddad, and E. Ghayad Neurologic manifestations in Behçet's disease. 16 cases in a cohort of 110 patients Ann Med Intern 148 1997 118 124
452. S. Tokay, H. Direskeneli, S. Yurdakul, and T. Akoglu Anticardiolipin antibodies in Behçet's disease: a reassessment Rheumatology 40 2001 192 195
453. E. Toker, H. Kazokoglu, and N. Acar High dose intravenous steroid therapy for severe posterior segment uveitis in Behçet's disease Br J Ophthalmol 86 2002 521 523
454. S.P. Travis, M. Czajkowski, and D.P. McGovern Treatment of intestinal Behçet's syndrome with chimeric tumor necrosis factor α antibody Gut 49 2001 725 728
455. G. Triolo, A. Accardo-Palumbo, and G. Triolo Enhancement of endothelial cell E-selectin expression by sera from patients with active Behçet's disease: moderate correlation with anti-endothelial cell antibodies and serum myeloperoxidase levels Clin Immunol 91 1999 330 337
456. G. Triolo, M. Vadalà, and A. Accardo-Palumbo Anti-tumor necrosis factor monoclonal antibody treatment for ocular Behçet's disease Ann Rheum Dis 61 2002 560 561
457. K.L. Tsui, K.W. Lee, and W.K. Chan Behçet's aortitis and aortic regurgitation: a report of two cases J Am Soc Echocardiogr 17 2004 83 86
458. I. Tugal-Tutkun, S. Önal, and R. Altan Yaycioglu Uveitis in Behçet's disease: an analysis of 880 patients Am J Ophthalmol 138 2004 373 380
459. I. Tugal-Tutkun, and M. Urgancioglu Childhood-onset uveitis in Behçet disease: a descriptive study of 36 cases Am J Ophthalmol 136 2003 1114 1119
460. M. Tunaci, B. Özkorkmaz, and A. Tunaci CT findings of pulmonary artery aneurysms during treatment for Behçet's disease AJR Am J Roentgenol 172 1999 729 733
461. R. Tunç, S. Saip, A. Siva, and H. Yazici Cerebral venous thrombosis is associated with major vessel disease in Behçet's syndrome Ann Rheum Dis 63 2004 1693 1694
462. B. Turan, H. Gallati, and H. Erdi Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behçet's disease; soluble TNFR-75 as a biological marker of disease activity J Rheumatol 24 1997 128 132
463. Y. Türköz, C. Evereklioglu, and N. Mehmet Plasma malondialdehyde levels in Behçet's disease with or without ocular involvement Adv Reprod 4 2000 31 36
464. U. Tursen, A. Gürler, and A. Boyvat Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet's disease Int J Dermatol 42 2003 346 351
465. Y. Tüzün, S. Yurdakul, and C.M. Mat Epidemiology of Behçet's syndrome in Turkey Int J Dermatol 35 1996 618 620
466. E. Uchio, T. Matsumoto, and S.I. Tanaka Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Behçet's disease and Vogt-Koyanagi-Harada's disease Clin Exp Rheumatol 17 1999 179 184
467. C. Üstün A famous Turkish dermatologist, Dr. Hulusi Behçet Eur J Dermatol 12 2002 469 470
468. S. Uzun, E. Alpsoy, M. Durdu, and A. Akman The clinical course of Behçet's disease in pregnancy: a retrospective analysis and review of the literature J Dermatol 30 2003 499 502
469. D.H. Verity, J.E. Marr, and S. Ohno Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives Tissue Antigens 54 1999 213 220
470. D.H. Verity, R.W. Vaughan, and E. Kondeatis Intercellular adhesion molecule-1 gene polymorphism in Behçet's disease Eur J Immunogenet 27 2000 73 76
471. D.H. Verity, R.W. Vaughan, and W. Madanat Factor V Leiden mutation is associated with ocular involvement in Behçet disease Am J Ophthalmol 128 1999 352 356
472. D.H. Verity, G.R. Wallace, and P.T. Seed Soluble adhesion molecules in Behçet's disease Ocul Immunol Inflamm 6 1998 81 92
473. D.H. Verity, G.R. Wallace, and R.W. Vaughan HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet's disease Tissue Antigens 54 1999 264 272
474. A. Vikas, S. Atul, and R. Singh Behçet's disease with relapsing cutaneous polyarteritis-nodosa-like lesions, responsive to oral cyclosporine therapy Dermatol Online J 9 2003 9
475. T.R. Vrabec Exudative retinal detachment in Behçet's disease Arch Ophthalmol 119 2001 1383 1386
476. N.J. Webb, C.R. Myers, and C.J. Watson Activated human neutrophils express vascular endothelial growth factor (VEGF) Cytokine 10 1998 254 257
477. B. Wechsler, L.T. Du, and E. Kieffer Cardiovascular manifestations of Behçet's disease Ann Med Interne 150 1999 542 554
478. B. Wechsler, R. Sable-Fourtassou, and B. Bodaghi Infliximab in refractory uveitis due to Behçet's disease Clin Exp Rheumatol 22 2004 14 16
479. S.M. Whincup, K.G. Csaky, and M.J. Podgor A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis Ophthalmology 103 1996 1054 1063
480. S.M. Whitcup, E.C. Salvo, and R.B. Nussenblatt Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease Am J Ophthalmol 118 1994 39 45
481. G. Wildner, and S.R. Thurau Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease Eur J Immunol 24 1994 2579 2585
482. ob) mice J Appl Physiol 89 2000 2382 2390
483. R. Wolf, B. Tüzün, and Y. Tüzün Dapsone: unapproved uses or indications Clin Dermatol 18 2000 37 53
484. M. Xiong, G. Elson, D. Legarda, and S.J. Leibovich Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway Am J Pathol 153 1998 587 598
485. *5101 with Behçet's disease in Greece Invest Ophthalmol Vis Sci 40 1999 1921 1926
486. I.S. Yalvaç, G. Sungur, and E. Turhan Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease J Glaucoma 13 2004 450 453
487. J.H. Yamamoto, M. Minami, and G. Inaba Cellular autoimmunity to retinal specific antigens in patients with Behçet's disease Br J Ophthalmol 77 1993 584 589
488. N. Yamashita Hyperreactivity of neutrophils and abnormal T cell homeostasis: a new insight for pathogenesis of Behçet's disease Int Rev Immunol 14 1997 11 19
489. N. Yamashita, H. Kaneoka, and S. Kaneko Role of γδ T lymphocytes in the development of Behçet's disease Clin Exp Immunol 107 1997 241 247
490. K. Yasui, K. Ohta, and M. Kobayashi Successful treatment of Behçet disease with pentoxifylline Ann Intern Med 124 1996 891 893
491. + cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçet's disease Arthritis Rheum 50 2004 3658 3662
492. + T cells in the peripheral blood of uveitis patients Br J Ophthalmol 83 1999 1386 1388
493. C. Yazici, K. Köse, and M. Çaliş Increased advanced oxidation protein products in Behçet's disease: a new activity marker? Br J Dermatol 151 2004 105 111
494. H. Yazici, G. Başaran, and V. Hamuryudan The ten-year mortality in Behçet's syndrome Br J Rheumatol 35 1996 139 141
495. H. Yazici Behçet's syndrome: where do we stand? Am J Med 112 2002 75 76
496. H. Yazici, and C.G. Barnes Practical treatment recommendations for pharmacotherapy of Behçet's syndrome Drugs 42 1991 796 804
497. H. Yazici, M.A. Chamberlain, and Y. Tüzün A comparative study of the pathergy reaction among Turkish and British patients with Behçet's disease Ann Rheum Dis 43 1984 74 75
498. H. Yazici, and Y. Özyazgan Medical management of Behçet's syndrome Dev Ophthalmol 31 1999 118 131
499. H. Yazici, H. Pazarli, and C.G. Barnes A controlled trial of azathioprine in Behçet's syndrome New Engl J Med 322 1990 281 285
500. H. Yazici, S. Yurdakul, and V. Hamuryudan Behçet disease Curr Opin Rheumatol 13 2001 18 22
501. Yeşilova Z, Pay S, Öktenli C,, et al. Hyperhomocysteinemia in patients with Behçet's disease: is it due to inflammation or therapy? Rheumatol Int (in press)
502. G. Yilmaz, S. Sizmaz, and E.D. Yilmaz Aqueous humor nitric oxide levels in patients with Behçet disease Retina 22 2002 330 335
503. A. Yoshida, H. Kawashima, and Y. Motoyama Comparison of patients with Behçet's disease in the 1980s and 1990s Ophthalmology 111 2004 810 815
504. S. Yoshida, K. Fujimori, M. Hareyama, and T. Nakata Cardiac thrombus in Behçet disease Chest 120 2001 688 689
505. T. Yoshida, M. Tanaka, and A. Sotomatsu Serum of Behçet's disease enhances superoxide production of normal neutrophils Free Radic Res 28 1998 39 44
506. + T cells and NKT cells increases in the aqueous humor of patients with Behçet's uveitis Clin Exp Immunol 137 2004 437 443
507. A.E. Yücel, H. Kart-Köseoglu, and Y.A. Akova Failure of infliximab treatment and occurrence of erythema nodosum during therapy in two patients with Behçet's disease Rheumatology 43 2004 394 396
508. S. Yurdakul, I. Günaydin, and Y. Tüzün The prevalence of Behçet's syndrome in a rural area in northern Turkey J Rheumatol 15 1988 820 822
509. S. Yurdakul, V. Hamuryudan, and H. Yazici Behçet syndrome Curr Opin Rheumatol 16 2004 38 42
510. S. Yurdakul, C. Mat, and Y. Tüzün A double-blind trial of colchicine in Behçet's syndrome Arthritis Rheum 44 2001 2686 2692
511. E. Zamir, B. Bodaghi, and I. Tugal-Tutkun Conjunctival ulcers in Behçet's disease Ophthalmology 110 2003 1137 1141
512. C.C. Zouboulis, I. Kötter, and D. Djawari Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe Yonsei Med J 38 1997 411 422
513. C.C. Zouboulis, and C.E. Orfanos Treatment of Adamantiades-Behçet disease with systemic interferon-α Arch Dermatol 134 1998 1010 1016
514. M.S. Zumbach, M.W. Boehme, and P. Wahl Tumor necrosis factor increases serum leptin levels in humans J Clin Endocrinol Metab 82 1997 4080 4082
515. N.W. Zwirner, K. Dole, and P. Stastny Differential surface expression of MICA by endothelial cells, fibroblasts, keratinocytes, and monocytes Hum Immunol 60 1999 323 330